Late-Breaking Abstract submission is now closed!

Stay informed of the latest announcements and deadlines by subscribing to the WSC 2022 mailing list.

August 3, 2022

Late-Breaking abstract submission deadline

End August 2022

Notifications to Late Breaking presenters

Rules for submission

Please read the submission rules before submitting an abstract.

• Late breaking scientific abstracts should contain new, scientifically rigorous information that has not been presented previously in a stroke conference. Results of a clinical trial should likely have a significant impact on clinical practice and/or to make significant advances in the stroke scientific field. We will accept trial that are completed after this submission deadline (3^rd August) but in time to release final results in a late-breaking session of WSC 2022.
• Such trials can be submitted to the late-breaking abstract submission. The clinical trial must include a comparison (usually a randomized controlled trial). Large Meta-analyses will be considered. It is also important to mention why the submitted science is of high impact. Late breaking abstract submission is open from 15 June 2022 to 3 August 2022.
• Abstracts must be submitted online via the website only.  ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
• The same person can present at the meeting on no more than 5 abstracts.  Beyond 5 abstracts, another co-author should be the presenting author.
• Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by the Early Registration Deadline will be scheduled in the program and included for publication in the International Journal of Stroke (IJS).
• Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Congress publications and in the International Journal of Stroke Abstract Book.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
• All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.
• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.
• Instructions for preparation of presentations will be made available on the Congress website.

Guidelines for submission

Before you begin, please prepare the following information:

Presenting author’s contact details:

• Full first and family name(s)
• Email address
• Affiliation details: department, institution / hospital, city, state (if relevant), country
• Phone number

Preferred presentation type:

• Free communication
• E-​Poster presentation

The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.

Author and co-authors’ details:

• Full first and family name(s)
• Affiliation details: department, institution / hospital, city, state (if relevant), country
• Abstract title – limited to 25 words in UPPER CASE. Please submit symbols as words.
• Abstract text – limited to 250 words including acknowledgements. Please note: Word count is affected when graphs/tables/images are added.
• Abstract topic– select the abstract topic per the list of topics.
• Images – The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format.
• Abstracts should clearly state:
  Background and aims
  Methods
  Results
  Conclusions
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers or other identifying information.
• The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline if not submitted, drafts will be deleted.
• Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
• You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact us if you have not received confirmation that your abstract has been submitted.
• Please do not submit multiple copies of the same abstract.

Abstract submitters’ declaration

During abstract submission you will be asked to confirm that you agree to the following:

• I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.
• Submission of the abstract constitutes the consent of all authors to publication (e.g. Congress website, programs, other promotions, etc.)
• The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to World Stroke Organization and Kenes International Organizers of Congresses SA and its affiliates (together: the “Organizers“), nor the publication of any such Content by each of the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
• The Abstract Submitter grants each of the Organizers the license and right to use, reproduce, publish, translate, distribute, and display the Content or any part thereof, in any manner and on any platform or media whatsoever, in each Organizer’s absolute discretion, on a royalty-free, perpetual, irrevocable nonexclusive basis.
• I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
• I understand that the presenting author must be a registered participant.
• The Organizers reserve the right to remove from publication and/or presentation an abstract that does not comply with the above.
• I understand that I must select a specific Topic for my abstract allocation. Although the Committee will work hard to honor this selection, this cannot be guaranteed.  The Committee reserves the right to change the Topic under which the abstract was originally submitted.